INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc.

Pomerantz LLP said it is investigating potential investor claims related to Sionna Therapeutics (NASDAQ: SION), advising affected investors to contact the firm. The news is primarily legal-process related with no disclosed financial magnitude, but it introduces uncertainty that could weigh on sentiment toward the company.